Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

Paterson, RW; Slattery, CF; Poole, T; Nicholas, JM; Magdalinou, NK; Toombs, J; Chapman, MD; ... Schott, JM; + view all Paterson, RW; Slattery, CF; Poole, T; Nicholas, JM; Magdalinou, NK; Toombs, J; Chapman, MD; Lunn, MP; Heslegrave, AJ; Foiani, MS; Weston, PSJ; Keshavan, A; Rohrer, JD; Rossor, MN; Warren, JD; Mummery, CJ; Blennow, K; Fox, NC; Zetterberg, H; Schott, JM; - view fewer (2018) Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer's Research & Therapy , 10 , Article 32. 10.1186/s13195-018-0361-3 . Green open access

https://ift.tt/2uxiUXH